Search Results - "Seymen, Hülya"
-
1
-
2
Can Ga-68 PSMA PET/CT replace conventional imaging modalities for primary lymph node and bone staging of prostate cancer?
Published in European urology focus (15-03-2020)“…Imaging is critical for primary staging of prostate cancer. Traditional imaging modalities (computerized tomography scan and nuclear medicine bone scans) are…”
Get full text
Journal Article -
3
Intraoperative Frozen Section via Neurosafe During Robotic Radical Prostatectomy in the Era of Preoperative Risk Stratifications and Primary Staging With mpMRI and PSMA-PET CT: Is There a Perfect Candidate?
Published in Clinical genitourinary cancer (01-10-2023)“…•The real challenge during a radical prostatectomy is establishing the balance between well spared neurovascular bundles and tumor-free surgical margins…”
Get full text
Journal Article -
4
Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy
Published in Prostate cancer and prostatic diseases (01-03-2021)“…Background To evaluate the additive role of Ga-68 PSMA PET as a primary staging tool in patients bearing prostate cancer in single PIRADS 4 or 5 index lesions…”
Get full text
Journal Article -
5
Radioligand Therapy With 177Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile
Published in Clinical nuclear medicine (01-12-2023)“…Introduction This study aimed to investigate the oncological outcomes and toxicity profile of 177 Lu-PSMA-I&T radioligand therapy (RLT) in patients with…”
Get full text
Journal Article -
6
Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results
Published in Clinical nuclear medicine (01-04-2020)“…PURPOSELu-PSMA inhibitor peptide receptor radioligand therapy (RLT) is playing an increasing role in metastatic castration-resistant prostate cancer. We aimed…”
Get full text
Journal Article -
7
18F-FDG PET/CT texture analysis of anthracotic lymph nodes detected with EBUS and comparison with cytological findings
Published in Hellenic journal of nuclear medicine (01-05-2022)“…OBJECTIVELymph node metastasis is the most important factor both in the selection of treatment since many alternatives have been created in recent years, and…”
Get full text
Journal Article -
8
Radioligand Therapy With 177 Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer : Oncological Outcomes and Toxicity Profile
Published in Clinical nuclear medicine (01-12-2023)“…INTRODUCTIONThis study aimed to investigate the oncological outcomes and toxicity profile of 177 Lu-PSMA-I&T radioligand therapy (RLT) in patients with…”
Get full text
Journal Article -
9
68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy: Central Review of Imaging and Comparison with Histopathology of Extended Lymphadenectomy
Published in European urology focus (01-03-2021)“…Results from prospective trials have shown higher accuracy of prostate-specific membrane antigen (PSMA)-based positron emission tomography (PET)/computed…”
Get full text
Journal Article -
10
68 Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy: Central Review of Imaging and Comparison with Histopathology of Extended Lymphadenectomy
Published in European urology focus (01-03-2021)“…Results from prospective trials have shown higher accuracy of prostate-specific membrane antigen (PSMA)-based positron emission tomography (PET)/computed…”
Get full text
Journal Article -
11
-
12
68 GaPSMA-11 PET/CT to monitor treatment response in patients with metastatic prostate cancer: The concordance between biochemical response and PSMA response
Published in Journal of clinical oncology (20-02-2023)“…49 Background: The aim of this study was to assess whether PSMA PET is associated with flares, with discordant results in regard to biochemical response, and…”
Get full text
Journal Article -
13
PD16-04 DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER
Published in The Journal of urology (01-04-2023)Get full text
Journal Article -
14
Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer
Published in Journal of clinical oncology (20-02-2023)“…56 Background: We aimed to evaluate the response of primary tumor to systemic treatment in patients with newly diagnosed mPCa with serial PSMA PET/CT scans…”
Get full text
Journal Article -
15
The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer
Published in The Prostate (01-01-2024)“…Introduction and Objectives To investigate the additive role of prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography…”
Get full text
Journal Article -
16
The role of PSMA PET/CT in predicting downgrading in patients with Gleason score 4+4 prostate cancer in prostate biopsy
Published in World journal of urology (21-05-2024)“…Background To investigate the predictable parameters associated with downgrading in patients with a Gleason score (GS) 8 (4+4) in prostate biopsy after radical…”
Get full text
Journal Article -
17
Diagnostic Performance of 68 Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results
Published in European urology focus (01-09-2023)“…Treatment response is traditionally monitored using prostate-specific antigen (PSA) and conventional imaging in patients with metastatic prostate cancer…”
Get full text
Journal Article -
18
Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results
Published in European urology focus (01-09-2023)“…BACKGROUNDTreatment response is traditionally monitored using prostate-specific antigen (PSA) and conventional imaging in patients with metastatic prostate…”
Get full text
Journal Article -
19
Visceral Calcification Diagnosed by Bone Scintigraphy
Published in Clinical nuclear medicine (01-05-2004)“…Chronic renal failure in a 47-year-old woman led to intense visceral calcification, mainly in the lungs, heart, and stomach. Changes secondary to multiple…”
Get full text
Journal Article -
20
Bone Tracer Uptake in Urinary Bladder Stones
Published in Clinical nuclear medicine (01-04-2003)Get full text
Journal Article